Janusz Rzeźniczak
Research Subjects
Janusz Rzeźniczak has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Paweł Burchardt
Klinika Intensywnej Terapii Kardiologicznej, Uniwersytet Medyczny im. K. Marcinkowskiego, Poznań
5 shared publications - Jan Budzianowski
Department of Interventional Cardiology and Cardiac Surgery, University of Zielona Gora, Collegium Medicum, Zielona Gora, Poland
4 shared publications - Dominika Kasprzak
Department of Cardiology, J. Strus Hospital, Poznan, Poland
3 shared publications - Jarosław Hiczkiewicz
University of Zielona Gora, Collegium Medicum, Department of Interventional Cardiology and Cardiac Surgery, Zielona Gora, Poland; Nowa Sol Multidisciplinar y Hospital, Nowa Sol, P oland
3 shared publications - Dariusz Hiczkiewicz
Department of Interventional Cardiology and Cardiac Surgery, Collegium Medicum, University of Zielona Góra, 65-046 Zielona Góra, Poland
2 shared publications - Jarosław Hiczkiewicz
Department of Interventional Cardiology and Cardiac Surgery, Collegium Medicum, University of Zielona Góra, 65-046 Zielona Góra, Poland
2 shared publications
Latest Publications
- Open Access
- 29 October 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (11) , 1705
Evaluation of Clinical and Genetic Determinants of Rivaroxaban Pharmacokinetics and Coagulation Parameters in Patients with Cardiovascular Diseases: An Exploratory Observational Study
Purpose: Interindividual variability in rivaroxaban exposure remains incompletely understood and may contribute to differences in treatment outcomes. This study aimed to investigate associations between polymorphisms in CYP3A4 (rs2242480), CYP2J2 (rs890293), and ABCB1 (rs1045642, rs2032582) genes, clinical factors and rivaroxaban pharmacokinetics. Methods: The study included 66 patients receiving 20 mg of rivaroxaban once daily. Rivaroxaban concentrations in plasma and dried blood spots were determined using a validated UPLC-MS/MS method. Genotyping was performed using PCR-RFLP. Associations between pharmacokinetic parameters, genetic variants and anthropometric characteristics, concomitant medications, comorbidities, and coagulation parameters were assessed using appropriate statistical analyses. Results: Carriers of the ABCB1 rs2032582 G allele exhibited lower rivaroxaban exposure, as reflected by reduced AUC0–12h values compared with non-carriers (1817.43 ± 703.70 vs. 2442.96 ± 691.13 ng·h/mL, nominal p = 0.0369). Concomitant use of eplerenone was associated with increased rivaroxaban exposure. Body mass composition and impaired renal function were associated with rivaroxaban concentrations. In addition, associations between CYP3A4 rs2242480 genotype and several body size descriptors, including body weight or lean body mass, and selected coagulation parameters were observed in exploratory analyses. However, most nominal associations did not remain statistically significant after correction for multiple comparisons. After Benjamini–Hochberg correction, only impaired renal function, drug interactions and biological sex remained statistically significant factors, impacting rivaroxaban’s pharmacokinetics and anticoagulant parameters. Conclusions: Several genetic and clinical factors showed nominal association with rivaroxaban pharmacokinetics and coagulation parameters in this study. These findings should be interpreted as exploratory given the limited sample size and the number of statistical comparisons. Further studies in larger cohorts are needed to clarify the clinical relevance of genetic and clinical determinants of rivaroxaban exposure.
- 29 October 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (11) , 1705
Open AccessEvaluation of Clinical and Genetic Determinants of Rivaroxaban Pharmacokinetics and Coagulation Parameters in Patients with Cardiovascular Diseases: An Exploratory Observational Study
Purpose: Interindividual variability in rivaroxaban exposure remains incompletely understood and may contribute to differences in treatment outcomes. This study aimed to investigate associations between polymorphisms in CYP3A4 (rs2242480), CYP2J2 (rs890293), and ABCB1 (rs1045642, rs2032582) genes, clinical factors and rivaroxaban pharmacokinetics. Methods: The study included 66 patients receiving 20 mg of rivaroxaban once daily. Rivaroxaban concentrations in plasma and dried blood spots were determined using a validated UPLC-MS/MS method. Genotyping was performed using PCR-RFLP. Associations between pharmacokinetic parameters, genetic variants and anthropometric characteristics, concomitant medications, comorbidities, and coagulation parameters were assessed using appropriate statistical analyses. Results: Carriers of the ABCB1 rs2032582 G allele exhibited lower rivaroxaban exposure, as reflected by reduced AUC0–12h values compared with non-carriers (1817.43 ± 703.70 vs. 2442.96 ± 691.13 ng·h/mL, nominal p = 0.0369). Concomitant use of eplerenone was associated with increased rivaroxaban exposure. Body mass composition and impaired renal function were associated with rivaroxaban concentrations. In addition, associations between CYP3A4 rs2242480 genotype and several body size descriptors, including body weight or lean body mass, and selected coagulation parameters were observed in exploratory analyses. However, most nominal associations did not remain statistically significant after correction for multiple comparisons. After Benjamini–Hochberg correction, only impaired renal function, drug interactions and biological sex remained statistically significant factors, impacting rivaroxaban’s pharmacokinetics and anticoagulant parameters. Conclusions: Several genetic and clinical factors showed nominal association with rivaroxaban pharmacokinetics and coagulation parameters in this study. These findings should be interpreted as exploratory given the limited sample size and the number of statistical comparisons. Further studies in larger cohorts are needed to clarify the clinical relevance of genetic and clinical determinants of rivaroxaban exposure.
- Open Access
- 15 February 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (4) , 1096
Predictors of Revascularization in Patients with Unstable Angina
Background: The factors that determine the necessity of coronary artery revascularization in patients with unstable angina (UA) have been supported by limited data. Therefore, this study aimed to identify the predictors of revascularization in patients with UA. Methods: The study included the recorded data of 3668 patients with UA who underwent cardiac catheterization (age 66 ± 9.2, men 70%); 2615 of them (71%) underwent revascularization (percutaneous transluminal coronary angioplasty (PTCA), coronary artery bypass graft (CABG), or hybrid revascularization. The remaining 1053 patients (29%) had no significant coronary stenosis and were regarded as controls. Multivariable logistic regression analysis was performed to separate the predictors of revascularization. Results: It was found that severe angina (OR 2.7, 95%CI 1.9–3.7), male gender (OR 1.4, 95%CI 1.1–1.7), and hyperlipidemia were the predictors of revascularization. It was also noted that intraventricular conduction disorders including left and right bundle branch blocks and a history of previous revascularization and myocardial infarction were associated with lower odds of revascularization. Conclusion: Overall, however, the predictive value of the studied factors proved to be poor and may still point to the multifactorial nature of significant coronary artery stenosis and the need for revascularization in patients with UA.
- 15 February 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (4) , 1096
Open AccessPredictors of Revascularization in Patients with Unstable Angina
Background: The factors that determine the necessity of coronary artery revascularization in patients with unstable angina (UA) have been supported by limited data. Therefore, this study aimed to identify the predictors of revascularization in patients with UA. Methods: The study included the recorded data of 3668 patients with UA who underwent cardiac catheterization (age 66 ± 9.2, men 70%); 2615 of them (71%) underwent revascularization (percutaneous transluminal coronary angioplasty (PTCA), coronary artery bypass graft (CABG), or hybrid revascularization. The remaining 1053 patients (29%) had no significant coronary stenosis and were regarded as controls. Multivariable logistic regression analysis was performed to separate the predictors of revascularization. Results: It was found that severe angina (OR 2.7, 95%CI 1.9–3.7), male gender (OR 1.4, 95%CI 1.1–1.7), and hyperlipidemia were the predictors of revascularization. It was also noted that intraventricular conduction disorders including left and right bundle branch blocks and a history of previous revascularization and myocardial infarction were associated with lower odds of revascularization. Conclusion: Overall, however, the predictive value of the studied factors proved to be poor and may still point to the multifactorial nature of significant coronary artery stenosis and the need for revascularization in patients with UA.
- Open Access
- 27 July 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (15) , 4954
Cognitive Impairment in Cardiovascular Patients after Myocardial Infarction: Prospective Clinical Study
(1) Background: Assessment of cognitive function is not routine in cardiac patients, and knowledge on the subject remains limited. The aim of this study was to assess post-myocardial infarction (MI) cognitive functioning in order to determine the frequency of cognitive impairment (CI) and to identify factors that may influence it. (2) Methods: A prospective study included 468 patients hospitalized for MI. Participants were assessed twice: during the first hospitalization and 6 months later. The Mini-Mental State Examination was used to assess the occurrence of CI. (3) Results: Cognitive dysfunction based on the MMSE was found in 37% (N-174) of patients during the first hospitalization. After 6 months, the prevalence of deficits decreased significantly to 25% (N-91) (p < 0.001). Patients with CI significantly differed from those without peri-infarction deficits in the GFR, BNP, ejection fraction and SYNTAX score, while after 6 months, significant differences were observed in LDL and HCT levels. There was a high prevalence of non-cognitive mental disorders among post-MI patients. (4) Conclusions: There is a high prevalence of CI and other non-cognitive mental disorders, such as depression, sleep disorders and a tendency to aggression, among post-MI patients. The analysis of the collected material indicates a significant impact of worse cardiac function expressed as EF and BNP, greater severity of coronary atherosclerosis expressed by SYNTAX results, and red blood cell parameters and LDL levels on the occurrence of CI in the post-MI patient population.
- 27 July 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (15) , 4954
Open AccessCognitive Impairment in Cardiovascular Patients after Myocardial Infarction: Prospective Clinical Study
(1) Background: Assessment of cognitive function is not routine in cardiac patients, and knowledge on the subject remains limited. The aim of this study was to assess post-myocardial infarction (MI) cognitive functioning in order to determine the frequency of cognitive impairment (CI) and to identify factors that may influence it. (2) Methods: A prospective study included 468 patients hospitalized for MI. Participants were assessed twice: during the first hospitalization and 6 months later. The Mini-Mental State Examination was used to assess the occurrence of CI. (3) Results: Cognitive dysfunction based on the MMSE was found in 37% (N-174) of patients during the first hospitalization. After 6 months, the prevalence of deficits decreased significantly to 25% (N-91) (p < 0.001). Patients with CI significantly differed from those without peri-infarction deficits in the GFR, BNP, ejection fraction and SYNTAX score, while after 6 months, significant differences were observed in LDL and HCT levels. There was a high prevalence of non-cognitive mental disorders among post-MI patients. (4) Conclusions: There is a high prevalence of CI and other non-cognitive mental disorders, such as depression, sleep disorders and a tendency to aggression, among post-MI patients. The analysis of the collected material indicates a significant impact of worse cardiac function expressed as EF and BNP, greater severity of coronary atherosclerosis expressed by SYNTAX results, and red blood cell parameters and LDL levels on the occurrence of CI in the post-MI patient population.
- Open Access
- 4 August 2021
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 16 (1)
A Review of Acute Coronary Syndrome and its Potential Impact on Cognitive Function
According to the World Health Organization (WHO) forecasts, in 2030, the number of people suffering from dementia will reach 82 million people worldwide, representing a huge burden on health and social care systems. Epidemiological data indicates a relationship between coronary heart disease (CHD) and the occurrence of cognitive impairment (CI) and dementia. It is known that both diseases have common risk factors. However, the impact of myocardial infarction (MI) on cognitive function remains controversial and largely unknown. The main goal of this study is to attempt to summarize and discuss selected scientific reports on the causes, mechanisms and effects of CI in patients after acute coronary syndrome (ACS), especially after MI. The risk of CI can increase in patients after ACS, and can therefore also adversely affect the further course of treatment. A late diagnosis of CI can lead to serious clinical implications, such as an increase in the number of hospitalizations and mortality.
- 4 August 2021
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 16 (1)
Open AccessA Review of Acute Coronary Syndrome and its Potential Impact on Cognitive Function
According to the World Health Organization (WHO) forecasts, in 2030, the number of people suffering from dementia will reach 82 million people worldwide, representing a huge burden on health and social care systems. Epidemiological data indicates a relationship between coronary heart disease (CHD) and the occurrence of cognitive impairment (CI) and dementia. It is known that both diseases have common risk factors. However, the impact of myocardial infarction (MI) on cognitive function remains controversial and largely unknown. The main goal of this study is to attempt to summarize and discuss selected scientific reports on the causes, mechanisms and effects of CI in patients after acute coronary syndrome (ACS), especially after MI. The risk of CI can increase in patients after ACS, and can therefore also adversely affect the further course of treatment. A late diagnosis of CI can lead to serious clinical implications, such as an increase in the number of hospitalizations and mortality.
- Open Access
- 18 June 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (12) , 2704
Patients with Non-Obstructive Coronary Artery Disease Require Strict Control of All Cardiovascular Risk Factors: Results from the Polish Local Population Medical Records
The aim of the project was to compare patients treated with percutaneous transluminal coronary angioplasty (PTCA), who also had undergone PTCA in the past, with a group of people who had had no angiographic stenosis in the lumen of the coronary arteries in the past, and who also required PTCA during index hospitalization. The secondary aim was to compare the obtained data with the characteristics of a group of people who had undergone angiography twice and for whom no significant stenosis had been found in their coronary arteries. The study used registry data concerning 3085 people who had undergone at least two invasive procedures. Acute coronary syndrome (ACS) was significantly more often observed (Non-ST-segment elevation myocardial infarction (NSTEMI) OR 2.76 [1.91–3.99] and ST-segment elevation myocardial infarction (STEMI) OR 2.35 [1.85–2.99]) in patients with no significant coronary stenosis in the past (who required coronary angioplasty at the time of the study), compared to patients who had already had PTCA. They also demonstrated more frequent occurrence of ‘multivessel disease’. This was probably most likely caused by inadequate control of cardiovascular risk factors, as determined by higher total cholesterol levels ([mg/dL] 193.7 ± 44.4 vs. 178.2 ± 43.7) and LDL (123.4 ± 36.2 vs. 117.7 ± 36.2). On the other hand, patients in whom no significant stenosis was found in two consecutive angiographies were more likely to be burdened with chronic obstructive pulmonary disease, atrial fibrillation and chronic kidney disease.
- 18 June 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (12) , 2704
Open AccessPatients with Non-Obstructive Coronary Artery Disease Require Strict Control of All Cardiovascular Risk Factors: Results from the Polish Local Population Medical Records
The aim of the project was to compare patients treated with percutaneous transluminal coronary angioplasty (PTCA), who also had undergone PTCA in the past, with a group of people who had had no angiographic stenosis in the lumen of the coronary arteries in the past, and who also required PTCA during index hospitalization. The secondary aim was to compare the obtained data with the characteristics of a group of people who had undergone angiography twice and for whom no significant stenosis had been found in their coronary arteries. The study used registry data concerning 3085 people who had undergone at least two invasive procedures. Acute coronary syndrome (ACS) was significantly more often observed (Non-ST-segment elevation myocardial infarction (NSTEMI) OR 2.76 [1.91–3.99] and ST-segment elevation myocardial infarction (STEMI) OR 2.35 [1.85–2.99]) in patients with no significant coronary stenosis in the past (who required coronary angioplasty at the time of the study), compared to patients who had already had PTCA. They also demonstrated more frequent occurrence of ‘multivessel disease’. This was probably most likely caused by inadequate control of cardiovascular risk factors, as determined by higher total cholesterol levels ([mg/dL] 193.7 ± 44.4 vs. 178.2 ± 43.7) and LDL (123.4 ± 36.2 vs. 117.7 ± 36.2). On the other hand, patients in whom no significant stenosis was found in two consecutive angiographies were more likely to be burdened with chronic obstructive pulmonary disease, atrial fibrillation and chronic kidney disease.
- Open Access
- 3 December 2018
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 16 (1) , 334
Machine-learned models using hematological inflammation markers in the prediction of short-term acute coronary syndrome outcomes
Increased systemic and local inflammation play a vital role in the pathophysiology of acute coronary syndrome. This study aimed to assess the usefulness of selected machine learning methods and hematological markers of inflammation in predicting short-term outcomes of acute coronary syndrome (ACS). We analyzed the predictive importance of laboratory and clinical features in 6769 hospitalizations of patients with ACS. Two binary classifications were considered: significant coronary lesion (SCL) or lack of SCL, and in-hospital death or survival. SCL was observed in 73% of patients. In-hospital mortality was observed in 1.4% of patients and it was higher in the case of patients with SCL. Ensembles of decision trees and decision rule models were trained to predict these classifications. The best performing model for in-hospital mortality was based on the dominance-based rough set approach and the full set of laboratory as well as clinical features. This model achieved 81 ± 2.4% sensitivity and 81.1 ± 0.5% specificity in the detection of in-hospital mortality. The models trained for SCL performed considerably worse. The best performing model for detecting SCL achieved 56.9 ± 0.2% sensitivity and 66.9 ± 0.2% specificity. Dominance rough set approach classifier operating on the full set of clinical and laboratory features identifies presence or absence of diabetes, systolic and diastolic blood pressure and prothrombin time as having the highest confirmation measures (best predictive value) in the detection of in-hospital mortality. When we used the limited set of variables, neutrophil count, age, systolic and diastolic pressure and heart rate (taken at admission) achieved the high feature importance scores (provided by the gradient boosted trees classifier) as well as the positive confirmation measures (provided by the dominance-based rough set approach classifier). Machine learned models can rely on the association between the elevated inflammatory markers and the short-term ACS outcomes to provide accurate predictions. Moreover, such models can help assess the usefulness of laboratory and clinical features in predicting the in-hospital mortality of ACS patients.
- 3 December 2018
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 16 (1) , 334
Open AccessMachine-learned models using hematological inflammation markers in the prediction of short-term acute coronary syndrome outcomes
Increased systemic and local inflammation play a vital role in the pathophysiology of acute coronary syndrome. This study aimed to assess the usefulness of selected machine learning methods and hematological markers of inflammation in predicting short-term outcomes of acute coronary syndrome (ACS). We analyzed the predictive importance of laboratory and clinical features in 6769 hospitalizations of patients with ACS. Two binary classifications were considered: significant coronary lesion (SCL) or lack of SCL, and in-hospital death or survival. SCL was observed in 73% of patients. In-hospital mortality was observed in 1.4% of patients and it was higher in the case of patients with SCL. Ensembles of decision trees and decision rule models were trained to predict these classifications. The best performing model for in-hospital mortality was based on the dominance-based rough set approach and the full set of laboratory as well as clinical features. This model achieved 81 ± 2.4% sensitivity and 81.1 ± 0.5% specificity in the detection of in-hospital mortality. The models trained for SCL performed considerably worse. The best performing model for detecting SCL achieved 56.9 ± 0.2% sensitivity and 66.9 ± 0.2% specificity. Dominance rough set approach classifier operating on the full set of clinical and laboratory features identifies presence or absence of diabetes, systolic and diastolic blood pressure and prothrombin time as having the highest confirmation measures (best predictive value) in the detection of in-hospital mortality. When we used the limited set of variables, neutrophil count, age, systolic and diastolic pressure and heart rate (taken at admission) achieved the high feature importance scores (provided by the gradient boosted trees classifier) as well as the positive confirmation measures (provided by the dominance-based rough set approach classifier). Machine learned models can rely on the association between the elevated inflammatory markers and the short-term ACS outcomes to provide accurate predictions. Moreover, such models can help assess the usefulness of laboratory and clinical features in predicting the in-hospital mortality of ACS patients.